MATTHEW WANAT to Anticoagulants
This is a "connection" page, showing publications MATTHEW WANAT has written about Anticoagulants.
Connection Strength
1.828
-
A comparison of anticoagulation, antiplatelet, and placebo treatment for patients with heart failure reduced ejection fraction in sinus rhythm: a systematic review and meta-analysis. Heart Fail Rev. 2020 03; 25(2):207-216.
Score: 0.446
-
Management of Anticoagulation with Impella? Percutaneous Ventricular Assist Devices and Review of New Literature. J Thromb Thrombolysis. 2019 Aug; 48(2):284-291.
Score: 0.429
-
Novel oral anticoagulants: a review of new agents. Postgrad Med. 2013 Jul; 125(4):103-14.
Score: 0.281
-
PF4/heparin antibody testing and treatment of heparin-induced thrombocytopenia in the intensive care unit. Clin Appl Thromb Hemost. 2013 Jun; 19(3):297-302.
Score: 0.256
-
Marginal structural models to evaluate the association between adherence to direct oral anticoagulants and safety or efficacy outcomes among patients with atrial fibrillation. J Am Pharm Assoc (2003). 2025 May-Jun; 65(3):102355.
Score: 0.157
-
Group-based trajectory modeling to identify adherence patterns for direct oral anticoagulants in Medicare beneficiaries with atrial fibrillation: a real-world study on medication adherence. Int J Clin Pharm. 2024 Dec; 46(6):1525-1535.
Score: 0.152
-
Medication taking behaviors in patients taking warfarin versus direct oral anticoagulants: A systematic review. Expert Rev Cardiovasc Ther. 2019 Jun; 17(6):427-434.
Score: 0.106